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Drug resistance in food-borne bacterial pathogens is an almost inevitable consequence of the use
of antimicrobial drugs, used either therapeutically or to avoid infections in food-producing
animals. In the past decades, the spread and inappropriate use of antibiotics have caused a
considerable increase of antibiotics to which bacteria have developed resistance and, moreover,
bacteria are becoming resistant to more than one antibiotic simultaneously. Understanding
mechanisms at the molecular level is extremely important to control multi-resistant strains and to
develop new therapeutic strategies. In the present study, comparative proteomics was applied to
characterize membrane and cytosolic proteome in order to investigate the regulation of protein
expression in multi-resistance E. coli isolated from young never vaccinated water buﬀalo. Results
highlighted diﬀerentially expressed proteins under multi drug resistance conditions giving new
insights about mechanisms involved in resistance, as quorum sensing mechanisms, and suggesting
possible novel bacterial targets to develop alternative antibiotic drugs.
Introduction
During the last century, after penicillin discovery, antibiotics
have reduced morbidity and mortality related to infectious
disease improving life quality and increasing life expectancy.1
However, the intensive use of antibiotics2,3 and the peculiar
adaptive capacity of bacterial genome have caused the world-
wide emergent phenomenon of antibiotic resistance, which
poses serious threats to human and animal health. Further-
more the number of antibiotics to which bacteria develop
resistance is considerably increasing and, at the same time, a
growing number of bacterial species are becoming resistant to
more than one antibiotic simultaneously.4 The main aim of
this study is the multi drug resistance in E. coli, which
represents a new challenge in antimicrobial drug research.
Antibiotic resistance is wide spread in E. coli entero-pathogen.
It represents the major global cause of food- or water-borne
illness and one of the most frequent causes of death in
developing countries due to complications like hemolytic or
uremic syndromes, which are responsible for acute renal
collapse in childhood5 especially if the E. coli serotype is
O157 or VTEC (verocytotoxin-producing E. coli). In E. coli,
multiple drug resistance to streptomycin, sulﬁsoxazole and
tetracycline is well documented6 and it has been associated
with failures in therapy of infectious disease7 both in human
and veterinary medicine. Therefore, new strategies are
required to control the diﬀusion and to decrease the incidence
of these pathologies. Few proteomic investigations on molecular
mechanisms related to one antibiotic resistance have been
reported, but only limited data are available on multi-drug
related molecular mechanisms. Studies on multiple antibiotic-
resistance reported for Salmonella enterica describe the role of
AcrAB–TolC eﬄux pumps and outer membrane proteins
(OM) in antibiotics and disinfectants resistance.4 In E. coli it
has been well described that the outer membrane proteins
(OM) are involved in streptomycin,8 nalidixic acid,9 chlortetra-
cycline10 and tetracycline resistance.11 The role of outer
membrane proteins and eﬄux channel is well established,
but it is not clear which signals are responsible for bacteria
speciﬁc activation. Interestingly, the existence of a possible
link between multi-drug eﬄux systems and quorum sensing
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has also been demonstrated.12 Typically, in Gram negative
bacteria, quorum sensing involves the production, the release
and the detection of auto-inducers (acylated homoserine lactone
signaling).13 Bacteria use this process for cell–cell communication
and for regulation of gene expression of cell community.14
Quorum sensing has been already described in pathogenesis
and virulence15 and in the formation of bioﬁlm. Furthermore,
in E. coli an increase in antibiotic resistance in mature bioﬁlm has
been observed.16
In the present study, an integrated approach based on two
dimensional electrophoresis (2DE) coupled with mass spectro-
metry (MS) techniques was used to resolve E. coli multiresistant
proteome, to investigate protein networks and to identify new
putative candidates involved in resistance mechanisms.
Materials and methods
Specimen collection
Diarrheic fecal samples from young water buﬀalo-calves,
recovered from diﬀerent farms located in the province of
Caserta (Southern Italy), were used in this study. All animals
showed similar clinical symptoms and history of diarrhea and
had never been vaccinated against E. coli infection. The
animals were 30 days old.
Bacteriological techniques
Samples were cultured after running an enrichment broth
Brain heart Infusion (BHI) incubated at 37 1C for 24 hours.
Loopful from these broth cultures were then streaked onto
Enterohaemolysin agar with blood (EHLY) and Sorbitol
MacConkey agar (SMAC) (both from Oxoid S.p.A., Milan,
Italy), and incubated at 37 1C for 24 hours. EHLY and SMAC
were used to search and to isolate haemolytic E. coli
and sorbitol-non-fermenting E. coli O157-H7, respectively.
Suspected colonies were identiﬁed morphologically, then bio-
chemically by the API 20E Kit system (bioMerieux, France).
As positive control, E. coli O157 strain ATCC 43895 was used
as quality control strains in each experiment.
E. coli O:157 latex test and serotyping
A latex agglutination test for the identiﬁcation of E. coli
serogroup O:157 was used (E. coli O:157 latex test, Oxoid).
Furthermore, the determination of O:111, O:26, O:157, O:128,
and O:103 antigens, employing antisera (Biolife Italiana Srl,
Milano, Italy), was carried out.
Antibiotic susceptibility testing
The antibiotic susceptibility test was run in duplicate for each
sample. Bacterial suspensions with a turbidity equivalent to
McFarland standard 0.5 were swabbed onto Muller Hinton
agar plates to determine antimicrobial susceptibility, and the
Bauer and Kirby disk diﬀusion technique was followed. The
following commercially available antibiotics discs at the indicated
concentrations were used: nalidixic 1 acid (NA 30 mg), neomycin
(N 30 mg) amoxicillin/clavulanic acid (AUG 30 mg), ampicillin
(AMP 10 mg), apramycin (APR 15 mg), colistin sulfate (CS 10 mg),
enroﬂoxacin (ENR 5 mg), gentamicin (CN 10 mg), tetracycline
(TE 30 mg), trimethoprim/sulfamethoxazole (SXT 25 mg), ceftiofur
(EFT 30 mg), lincomycin (MY 2 mg), penicillin G (P 10 mg). Plates
were incubated for 24 h at 37 1C followed by measuring the
diameters of the inhibition zones, including the diameter of the
disc (mm).
Protein extraction for 2D electrophoresis
Three biological replicates were performed for 2D electro-
phoresis analysis.
Protein extraction was performed as previously described,17
adapting protocol to E. coli samples. Bacteria were harvested at
9000g, at 4 1C, for 10 minutes and quickly washed ﬁve times with
cold PBS. Cellular pellets for 2-DE analysis were suspended in
lysis buﬀer (9.5 M urea, 4% CHAPS, 1% DTT, 10 mM TRIS)
containing protease inhibitors cocktail (GE Healthcare) accord-
ing to the manufacturer’s instructions and disrupted by sonica-
tion 5 times for 4 min at maximum power on ice. Cell debris were
removed by centrifugation at 9000g, at 20 1C, for 60 min. To
minimize contamination by lipids, phospholipids and other cell
constituents, the supernatant was cleaned by precipitation18
using a solution consisting of tri-n-butyl phosphate : acetone :
methanol (1 : 12 : 1), cooled on ice. 1.4 ml of this solution were
added to each sample to reach a ﬁnal acetone concentration of
80% (v/v) and incubated at 4 1C for 90 min. The precipitate was
isolated by centrifugation at 9000g, for 20 minutes at 4 1C. After
washing with the same precipitant buﬀer, it was centrifuged
again and then air dried. Cellular pellets were re-suspended in
8 M urea, 4% CHAPS, 1% DTT, 10 mM TRIS and 2%
Ampholine pH 3.5–10 containing nuclease mix (GE Healthcare)
to remove nucleic acids. Protein concentration in all samples was
determined using 2D Quant Kit (GE Healthcare).
2D electrophoresis and image analysis
Euroclone immobilized pH gradient (IPG) strips (EMP052040,
13 cm) with a linear pH range of 4.0–8.0 were rehydrated
overnight in a buﬀer containing 8 M urea, 4% CHAPS, 1%
DTT, 10 mM TRIS and 2% Ampholine pH 3.5–10. 100 mg of
protein sample were loaded on each IPG strip using cup loading
at the cathodic side. Isoelectric focusing was performed using an
Ettan IPGphor III IEF system (GE Healthcare) at 20 1C with a
current of 120 mA per strip. For IEF the following protocol was
used: 30 V (4 h), 50 V (3 h), 100 V (3 h), 500 V (3 h), 1000 V (3 h),
3000 V (3 h), 4000 V (3 h), 6000 V (3 h) and 8000 V (8 h). After
the ﬁrst dimension, IPG strips were equilibrated twice with a
solution containing 6M urea, 2% SDS, 50 mMTris–HCl pH 8.8
and 30% glycerol, for 15 min, under gentle stirring. For the ﬁrst
equilibration step was used 1% DTT and for the second 2.5%
iodoacetamide. The second dimension was performed using
homemade 12% acrylamide gradient vertical SDS-PAGE slab
gels (13  13  0.1 cm) on a Protean II cell (BioRad). IPG strips
were put on top of the SDS gels which were poured up to 1 cm
from the top of the plates and then sealed with 1.5 ml of a
solution containing 0.5% low-melting-point agarose diluted in
hot SDS running buﬀer (25 mM Tris–HCl pH 8.3, 192 mM
glycine, 0.1%SDS).Molecular weight proteinmarkers (Invitrogen)
were applied on one end of the IPG strips. In the second
dimension, gels were run at 15 mA per gel, for 20 min and then
at 40 mA per gel, until the bromophenol blue front-line came
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Coomassie and digitalized with PharosFX Plus Laser Imaging
System (BioRad). For 2-DE three experimental replicates were
performed for each sample. Gel images were imported both
into Progenesis SameSpots (v3.33.3383; Nonlinear Dynamics,
Newcastle, UK) and ImageMaster 2D Platinum v6.0.1 soft-
ware (GE Healthcare) for analysis. All imported images were
processed to check image quality (saturation, dimension,
background). The aligned images were then automatically
analyzed using the 2D analysis module for spot detection,
background subtraction, normalization, and spot matching,
and all spots were manually reviewed and validated to ensure
proper detection and matching. Statistical analysis was per-
formed by the Progenesis Stats module on the log-normalized
volumes for all spots. Student’s t-test and one-way ANOVA
were used to conﬁrm the p value between diﬀerent groups,
p-values under 0.05 were considered statistically signiﬁcant.
In situ digestion
Diﬀerentially expressed proteins were excised from Colloidal
Coomassie-stained gel and destained by sequential washes with
0.1 M NH4HCO3 pH 7.5 and acetonitrile. Samples were reduced
by incubation with 50 ml of 10 mM DTT in 0.1 M NH4HCO3
buﬀer pH 7.5 and carboxyamidomethylated with 50 ml of 55 mM
iodoacetamide in the same buﬀer. Enzymatic digestion was
carried out with trypsin (12.5 ng ml1) in 10 mM ammonium
bicarbonate pH 7.8 with 2 hours incubation at 4 1C. Trypsin
solution was then removed and a new aliquot of the digestion
solution was added; samples were incubated for 18 h at 37 1C. A
minimum reaction volume was used to obtain the complete
re-hydration of gel. Peptides were then extracted by washing the
gel particles with 10 mM ammonium bicarbonate and 1% formic
acid in 50% acetonitrile at room temperature. The resulting
peptide mixtures were desalted using ZipTip pipettes from Milli-
pore, following the recommended puriﬁcation procedure.
MALDI-TOF mass spectrometry
Positive Reﬂectron MALDI spectra were recorded on a
Voyager DE STR instrument (Applied Biosystems, Framingham,
MA). The MALDI matrix was prepared by dissolving 10 mg of
alpha cyano in 1 ml of acetonitrile/water (90 : 10 v/v). Typically,
1 ml of matrix was applied to the metallic sample plate and 1 ml of
analyte was then added. Acceleration and reﬂector voltages were
set up as follows: target voltage at 20 kV, ﬁrst grid at 95% of
target voltage, delayed extraction at 600 ns to obtain the best
signal-to-noise ratios and the best possible isotopic resolution with
multipoint external calibration using peptide mixture purchased
from Applied Biosystems. Each spectrum represents the sum of
1500 laser pulses from randomly chosen spots  sample position.
Raw data were analyzed using the computer software provided by
the manufacturers and are reported as monoisotopic masses.
Nano HPLC-chip MS/MS analysis
LC/MS/MS analyses were performed on a LC/MSD Trap
XCT Ultra (Agilent Technologies, PaloAlto, CA) equipped
with a 1100HPLC system and a chip cube (Agilent Technologies).
After loading, the peptide mixture was ﬁrst concentrated and
washed in a 40 nL enrichment column (Agilent Technologies
chip), with 0.2% formic acid in 2% acetonitrile as the eluent.
The sample was then fractionated on a C18 reverse-phase capillary
column (Agilent Technologies chip) at a ﬂow rate of 300 nl min1,
with a linear gradient of eluent B (0.2% formic acid in 95%
acetonitrile) in A (0.2% formic acid in 2% acetonitrile) from 7%
to 60% in 50 min. Peptide analysis was performed using data-
dependent acquisition of one MS scan (mass range from 300 to
1800 m/z) followed by MS/MS scans of the three most abundant
ions in each MS scan. Dynamic exclusion was used to acquire a
more complete survey of the peptides by automatic recognition
and temporary exclusion (2 min) of ions from which deﬁnitive
mass spectral data had previously acquired. Nitrogen at a ﬂow
rate of 3 l min1 and heated to 325 1C was used as the dry gas for
spray desolvation. MS/MS spectra were measured automatically
when the MS signal surpassed the threshold of 50000 counts.
Double charged ions were preferably isolated and fragmented
over single charged ions. The acquired MS/MS spectra were
transformed in Mascot generic ﬁle format and used for peptides
identiﬁcation with a licensed version of MASCOT, in a local
database.
Protein identiﬁcation
Spectral data were analyzed using Analyst software (version 1.4.1)
and MSMS centroid peak lists were generated using the
MASCOT.dll script (version 1.6b9). MSMS centroid peaks were
threshold at 0.1% of the base peak. MSMS spectra having less
than 10 peaks were rejected. MSMS spectra were searched against
SwissProt database using the upgrade licensed version of Mascot
2.1 (Matrix Science), after converting the acquired MSMS spectra
in Mascot generic ﬁle format. The Mascot search parameters
were: taxonomy ‘‘Escherichia coli’’; ‘‘trypsin’’ as enzyme allowing
up to 2 missed cleavages, carbamidomethyl as ﬁxed modiﬁcation,
oxidation of M, pyro-Glu (N-term Q), as variable modiﬁcations,
600 ppm MSMS tolerance and 0.6 Da peptide tolerance and top
20 protein entries. Spectra with a MASCOT score ofo25 having
low quality were rejected. The score used to evaluate quality of
matches for MSMS data was higher than 30.
Results
Antibiotic susceptibility test
An antibiotic susceptibility test was performed on all 57 E. coli
O157 isolated. Results were interpreted according to the
guidelines of the Clinical Laboratories Standards Institute
breakpoints (National Committee for Clinical Laboratory
Standards 2002). Susceptibility to 13 diﬀerent antibiotics was
evaluated on all 57 E. coli isolated with the following results in
terms of resistance percentage (Fig. 1): augmentin (42%),
ampicillin (43, 8%), nalidixicacid and apramycin (17, 5%),
colistinsulfate (1%), enroﬂoxacine (8, 7%), gentamicin (7%),
ceftiofur (3, 5%), lincomycin and penicillin (100%), tetra-
cycline (22, 8%), neomycin (71, 9%) and sulfamethoxazole/
trimethoprim (14%). All samples were found to be resistant to
penicillin and lincomycin and a high prevalence of resistance
to augmentin, neomycin and ampicillin was also found. Of all
57 samples 12 were selected on the basis of their resistance
proﬁles and then included in this study. All 12 selected samples
(Table 1) were resistant to lincomycin, penicillin (taking into
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and lincomycin) and N (neomycine); only one sample (no. 1)
resulted to be resistant to CS (colistinsulfate). A comparative
proteomic analysis was performed considering the number of
antibiotics to which bacteria were resistant and grouping samples
into multi resistant (MR) and control (C): the MR group
includes bacteria resistant to more than ﬁve antibiotics, while
the C group includes bacteria resistant to a maximum of one
antibiotic, excluding P, MY and N because all bacteria were
resistant.
2D electrophoresis and protein identiﬁcation
Quantitative two dimensional electrophoresis was performed
on the 12 selected samples with diﬀerent antibiotic resistance
proﬁles (Table 1). Image analysis highlighted 21 signiﬁcantly
altered spots (p-value r 0.05) under MR versus C conditions
successfully identiﬁed by mass spectrometry as shown in
Fig. 2. Spots of interest were excised, destained by repetitive
washings and in situ digested with trypsin. The resulting
peptide mixtures were extracted from the gel and directly
analyzed by MALDI-MS. When the identiﬁcation was uncertain
the peptide mixture was analyzed by nano LC/MS/MS generating
sequence information on individual peptides. This information
together with the peptide mass values was then used to search in
protein databases leading to the identiﬁcation of protein compo-
nents as reported in Table 2. Identiﬁed proteins were both up and
down regulated in the MR group and involved in several cellular
mechanisms such as metabolism, stress-response, protein folding
and trans-membrane transport and are localized either at the
membrane or cytoplasmic level. In Table 3 is indicated in the ﬁrst
column the protein name, in the second column the protein regula-
tion with the percentage of variation in resistant strains (MR: multi
resistant) compared to non-resistant (C: control). In the third and in
the fourth column, respectively, is reported the biological process
where the protein is involved and the cellular localization. Results
were investigated and grouped on the basis of protein function.
Major diﬀerences were found in proteins involved in metabolism
and transport at membrane levels as outer membrane protease,
thiosulfate binding protein and zinc transport protein (Fig. 3,
Tables 2 and 3). Furthermore, curved DNA-binding protein and
S-ribosylhomocysteinelyase were up regulated under high resistance
conditions. DNA-binding proteins are linked in adaptive
response to environmental stress,19 while S-ribosylhomo-
cysteinelyase (Fig. 4), also called luxS protein, is involved in
quorum sensing mechanisms. FKBP-type peptidyl-prolyl
cis–trans isomerase 1 fkpa, a periplasmic isomerase involved
in protein folding was down regulated. Otherwise, secreted
protein hcp (major exported protein, spot 8) was apparently
expressed only in the unique sample resistant to CS (Fig. 5).
Metabolic proteins
Regarding energetic metabolism, eight proteins were diﬀerentially
expressed in the MR versus C group; fructose bisphosphate
Fig. 1 Number of bacteria resistant to each tested antibiotic, con-
sidering 57 isolates. NA: nalidixic acid, AUG: augmentin, AMP:
ampicillin, APR: apramycin, CS: colistin sulfate, ENR: enroﬂoxacine,
CN: gentamicin, EFT: ceftiofur, MY: lincomycin, P: penicillin, TE:
tetracycline, N: neomycine, SXT: sulfamethoxazole/trimethoprim.
Table 1 Antibiotic resistance proﬁle related to samples included in this study. ‘R’ means resistance to the tested antibiotic. On the basis of the
resistance/susceptibility test, samples were classiﬁed into C and MR groups. C group: samples 1, 2, 8, 10, 11, and 12 (resistant to a maximum of 1
antibiotic, excluding MY, P and N common to all); MR group: 3, 4, 5, 6, 7, and 9
Sample NA AUG AMP APR CS ENR CN EFT MY P TE N SXT
1 R R R R
2 R R R
3 R R R R R R R R R R R
4 R R R R R R R R R
5 R R R R R R R R
6 R R R R
7 R R R R R R R R R R R
8 R R R
9 R R R R R R R R R R R
10 R R R
11 R R R
12 R R R
Fig. 2 E. coli 2D master map summarizing all diﬀerentially expressed
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aldolase, glyceraldehyde-3-phosphate dehydrogenase and trio-
sephosphateisomerase are glycolytic enzymes, phosphoglucomu-
tase is involved in glucose metabolism, both breakdown and
synthesis; malate dehydrogenase is a well known protein which
takes part in the Krebs cycle. These proteins were up regulated
in high resistant bacteria as shown in Table 3. Other three
proteins were found to be down regulated in the MR group:
fumarate reductase iron–sulfur subunit, is a part of fumarate
reductase, activated during the anaerobic growth of bacteria,
isocitrate dehydrogenase involved in the tricarboxylic acid
cycle and ATP synthase gamma chain, involved in the production
of ATP from ADP in the presence of a proton gradient across
the membrane. Furthermore, 3-oxoacyl-[ACP] reductase and
enoyl-[ACP] reductase were down regulated in MR; these
proteins belong to the short-chain dehydrogenase/reductase
family, involved in oxidation–reduction reactions and in particular
in fatty acid biosynthesis. Cystein synthase A and phosphoserine
aminotransferase are transferase enzymes involved in aminoacid
biosynthesis, respectively, cysteine synthesis and serine synthesis.
They were upregulated in MR bacteria (Tables 2 and 3).
Membrane and transport proteins
Three membrane proteins, which are responsible for trans-
membrane transport and alterations of cell permeability, were
upregulated in theMR group (Fig. 3). Thiosulfate-binding protein
is involved in trans membrane transport of sulfate/thiosulfate at
outer membrane levels and zinc transport protein B mediates the
eﬄux of zinc ions at inner membrane levels. Furthermore, outer
membrane protease ompP, is a protease, belonging to the A26
Table 2 Protein identiﬁcation by MALDI/MS and LC/MS/MS analysis. Accession number is linked to www.expasy.org
Spot Protein name Trend in MR vs. control (%) Accession no. MW/Da Seq. coverage Mascot score
1 Isocitrate dehydrogenase k16 P08200 45 757 26% 66
2 Outer membrane protease ompP m+55 P34210 35 499 30% 99
3 Phosphoglucomutase m+80 P36938 58 361 15% 64
4 Terminase, ATPase subunit m+19 P25479 66 571 18% 63
5 Glyceraldehyde-3-phosphate dehydrogenase m+29 P0A9B4 35 532 54% 124
6 Curved-DNA-binding protein m+15 P36659 34 445 23% 65
7 Thiosulfate binding protein m+80 P16700 37 615 26% 54
8 Major exported protein m+55 Q9HI36 19 091 50% 86
9 3-Oxoacyl-[ACP] reductase k35 P0AEK2 25 560 42% 79
10 S-Ribosylhomocysteine lyase m+71 Q8FEP8 19 443 43% 66
11 Enoyl-[ACP] reductase k13 P0AEK5 27 864 29% 72
12 Malate dehydrogenase m+34 P61889 32 337 42% 151
13 FKBP-Type P–P cis–trans isomerase FKPA k10 P65765 28 912 34% 91
14 Glutamine-binding-periplasmic protein k27 P0AEQ5 27 190 58% 110
15 Triosephosphate isomerase m+24 P0A858 26 972 45% 145
16 Cysteine synthase A m+29 P0ABk6 34 490 56% 156
17 Fumarate reductase iron–sulfur subunit k24 P0AC49 27 123 47% 157
18 Zinc transport protein zntB m+80 P64423 36 612 1 peptide 25
19 Fructose bisphosphate aldolase class I m+66 P0A992 38 109 1 peptide 66
20 Phosphoserine aminotransferase m+36 P23721 39 783 1 peptide 77
21 ATP synthase gamma chain k21 P0ABA6 31 577 1 peptide 25
Table 3 Function, cellular localization and regulation of identiﬁed proteins changing their expression in MR E. coli
Protein Trend in MR vs. control Biological process Cellular localization
Malate dehydrogenase m Tricarboxylic acid cycle Cytosol
Fructose-bisphosphate aldolase m Glycolysis Cytosol
Glycera1dehyde-3-phosphate dehydrogenase A m Glycolysis Cytosol
Triosephosphate isomerase m Glycolysis Cytosol
Phosphoglucomutase m Glucose metabolism Cytosol
Isocitrate dehydrogenase[NADP] k Tricarboxylic acid cycle Cytosol
Fumarate reductase iron–sulfur subunit k Electron transport chain Cytosol
ATP synthase gamma chain k ATP synthesis Plasma membrane
Enoyl-[acyl-carrier-protein] reductase [NADH] k Fatty acid biosynthesis Plasma membrane
3-Oxoacyl-[acyl-carrier-protein] reductase k Fatty acid biosynthesis Plasma membrane
Curved DNA-binding protein m Molecular chaperon Cytosol
FKBP-type peptidyl-prolyl cis–trans isomerase fkpa k Protein folding Periplasm
Glutamine-binding periplasmic protein k Amino acid transport Periplasm
Cysteine synthase A m L-Cysteine biosynthesis Cytosol
Phosphoserine aminotransferase m L-Serine biosynthesis Cytosol
S-Ribosylhomocysteine lyase m Synthesis of autoinducer II Cytosol
Terminase, ATPase subunit m DNA packaging Cytosol
Outer membrane protease ompP m Receptor Plasma membrane
Zinc transport protein m Ion transport Plasma membrane
Thiosulfate binding protein m Ion transport/ABC complex Periplasm
Major export protein ma Secreted Extracellular region
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peptidase family, which acts also as a receptor for bacteriophage
Ox2 in the cell outer membrane; it is a trans-membrane protein.
Otherwise, glutamine binding protein, involved in the glutamine
transport system, belonging to the bacterial solute-binding protein
3 family, was down regulated in the MR group (Table 3).
Discussion
Multi-drug resistance in bacteria has frequently been reported,
but information regarding proteomic proﬁle changes is avail-
able only for bacteria resistant to a singular antibiotic. In this
study 21 diﬀerentially expressed proteins were identiﬁed,
giving new insights on antibiotic resistance in Gram negative
bacteria and showing a global view of cell metabolism changes
related to this condition.
The relevance of eﬄux pumps and outer membrane proteins
This study conﬁrms the relevance of membrane and cell wall
systems in antibiotic resistance mechanisms, as previously
reported.20,21 Thiosulfate-binding protein, over expressed in
MR, belongs to the ABC (ATP binding cassette) transporter
complex cysAWTP,22 and it is involved in sulfate/thiosulfate
import. This protein speciﬁcally binds thiosulfate allowing its
transmembrane transport. The ABC system is responsible for
transporting toxic compounds such as drugs, toxins, and deter-
gents. Eﬄux pumps signiﬁcantly contribute to bacterial resis-
tance acquisition because of their broad variety of substrates
recognized, their cooperation with other mechanisms of resis-
tance and their expression in important pathogens, such as
E. coli, Pseudomonas aeruginosa, Staphylococcus aureus and
Salmonella enterica sv Typhimurium.23 Zinc transport protein
zntB has a similar function, mediating eﬄux of zinc ions at the
cell inner membrane level.24 It is part of the corA metal ion
transporter family (MIT). Diﬀerential expression of these pro-
teins inMR and C is shown in Fig. 3. Few data are available on a
possible role of MIT 1 in oxidative stress response in E. coli and
Salmonella enterica,25 but the role of ion transporters in drug
resistance is well established.26 Outer membrane protease ompP
is a member of a unique family of bacterial endopeptidases
known as omptins, which includes OmpT and OmpP of
E. coli, SopA of Shigella ﬂexneri, PgtE of Salmonella enterica
and Pla of Yersinia pestis.27 The role of outer membrane proteins
is the subject of many studies on pathogenesis, virulence and
resistance in bacteria; most of the omptin proteins have been
implicated in bacterial pathogenesis and they are potential targets
of antimicrobial drugs and vaccine development.27
Quorum sensing and antibiotic resistance
Interestingly, S-ribosylhomocysteinelyase, an up-regulated pro-
tein in antibiotic resistant bacteria (Fig. 4), is involved in the
synthesis of autoinducers 2 (AI-2) which are small molecules
(acylated homoserine lactone) secreted by bacteria and used to
communicate both cell density and metabolic potential of the
environment.14 This regulation mechanism, called quorum sen-
sing, plays an important role in many cellular mechanisms, such
as expression of bioluminescence in marine bacteria, virulence,
pathogenesis and bioﬁlm formation (Fig. 6).28,29 Furthermore, a
possible role of quorum sensing in the regulation of multidrug
eﬄux pumps has been described,12 but there is no evidence
regarding its possible implication in antibiotic resistance. The
over expression of S-ribosylhomocysteinelyase in antibiotic re-
sistance enforces previous ﬁndings which indicate quorum sen-
sing as global regulatory systems in E. coli,29 and enhances the
existing knowledge suggesting its possible role in multi-drug
resistance. Such a role would also be related to the formation
of bioﬁlm, which, as previously described,16 can be involved in
drug resistance.
Metabolism changes overview
This study gave a global overview of metabolism-related changes
which can occur in high drug-resistant cells. In particular, most
Fig. 3 Diﬀerential expression of outer membrane protease (spot 1),
thiosulfate binding protein (spot 7) and zinc transport protein B (spot
18). Y-axis reports spot normalized volume, X-axis reports the expres-
sion of proteins in MR and C.
Fig. 4 Up regulation of S-ribosylhomocysteine lyase: MR vs. C.
Fig. 5 Diﬀerential expression of major exported protein hcp1 in
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dramatic changes are related to energetic metabolism and glyco-
lysis, suggesting an increase of sugar metabolism, probably due
to an increased need in ATP production, which is fundamental
for active membrane transport systems. An ATP synthase
gamma chain, involved in production of ATP from ADP in
the presence of a proton gradient across the membrane, is down
regulated in MR bacteria (Tables 2 and 3) and isocitrate
dehydrogenase and fumarate reductase iron–sulfur subunit were
down regulated: they are involved in an alternative route to
glycolysis for carbon metabolism and anaerobic cellular growth.
Enoyl-[acyl-carrier-protein] reductase and 3-oxoacyl-[acyl-
carrier-protein] reductase are enzymes involved in lipid biosynthesis:
they are down regulated in antibiotic resistant bacteria indicating a
possible decrease of lipid metabolism in response to an increased
sugar metabolism.
Regarding amino acid metabolism, cysteine synthase A and
phosphoserine aminotransferase were up regulated in MR vs.
C: this indicates a possible regulation also for amino acid
biosynthesis. Currently, there is no reported evidence regarding
such ﬁndings, but these two enzymes are co-regulated, because
cysteine is synthesized from serine.
Colistin sulfate resistance
As shown in Fig. 5, secreted protein hcp (spot 8) was found only
in the colistin sulfate resistant sample; this protein could be
present in other gels, but under the limit of detection of the
staining method used. Secreted protein hcp is one of the hemo-
lysis co-regulated proteins (hcp1 family), described inPseudomonas
aeruginosa which is involved in pathogenesis and virulence
associated to cystic ﬁbrosis.30 As reported, secreted proteins often
represent important virulence factors and, interestingly, their
regulation is associated to quorum sensing.31
Conclusions
The aim of this work was to give new suggestion to individuate
molecular targets for anti-microbial drugs, using 2-dimensional
electrophoresis and mass spectrometry. Results obtained with
comparative proteomics gave an overview of metabolism changes
and the importance of membrane outer proteins and membrane
active eﬄux pumps in multi resistant bacteria. Moreover, this
study gave new insights regarding molecular mechanisms related
to antibiotic resistance suggesting a possible role of quorum
sensing as a central regulatory mechanism of gene expression in
multi drug resistance.
Moreover our ﬁndings improve the understanding of func-
tional regulation of antibiotic resistance in E. coli and give new
interesting suggestions like the involvement of quorum sensing in
antibiotic resistance, a theory that was previously hypothesized,
but never supported by experimental data. The strong up
regulation of S-ribosylhomocysteinelyase, involved in quorum-
sensing mechanisms, could be suggested as a possible target
mechanism for developing new generation antibiotic drugs.
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